secwatch.observer — SEC 8-K summary
======================================

Issuer:     WEST PHARMACEUTICAL SERVICES INC (WST)
CIK:        0000105770
Form:       8-K
Filed at:   2022-07-27T23:59:59+00:00
Accession:  0000105770-22-000038
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

West Pharma adds Dr. Stephen Lockhart as director; $90K retainer + $190K RSU
----------------------------------------------------------------------------

- Elected July 26, 2022; Board expands to 11 members.
- Dr. Lockhart, former CMO of Sutter Health, appointed to Innovation & Technology and Finance Committees.
- Receives prorated $90,000 annual cash retainer and $190,000 annual RSU grant (grant date Aug 1, 2022).
- Also eligible for Director Deferred Compensation Plan and standard indemnification agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/105770/000010577022000038/0000105770-22-000038-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/105770/000010577022000038/wst-20220726.htm
  HTML page:      https://secwatch.observer/filing/0000105770-22-000038

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer